ID22930A - Steroid-steroid 4-terhalogenasi baru, proses pembuatan dan zat-zat antaranya, penggunaannya sebagai obat dan komposisi farmasi yang mengandung steroid 4-terhalogenasi - Google Patents

Steroid-steroid 4-terhalogenasi baru, proses pembuatan dan zat-zat antaranya, penggunaannya sebagai obat dan komposisi farmasi yang mengandung steroid 4-terhalogenasi

Info

Publication number
ID22930A
ID22930A IDW991174A ID991174A ID22930A ID 22930 A ID22930 A ID 22930A ID W991174 A IDW991174 A ID W991174A ID 991174 A ID991174 A ID 991174A ID 22930 A ID22930 A ID 22930A
Authority
ID
Indonesia
Prior art keywords
terhalogenation
terhalogen
steroids
steroid
substances
Prior art date
Application number
IDW991174A
Other languages
English (en)
Indonesian (id)
Inventor
Yamina Bouali
Francois Nique
Jean-Georges Teutsch
Patrick Van De Velde
Original Assignee
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel Inc
Publication of ID22930A publication Critical patent/ID22930A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0077—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom
    • C07J41/0083—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom substituted in position 11-beta by an optionally substituted phenyl group not further condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IDW991174A 1997-04-09 1998-04-08 Steroid-steroid 4-terhalogenasi baru, proses pembuatan dan zat-zat antaranya, penggunaannya sebagai obat dan komposisi farmasi yang mengandung steroid 4-terhalogenasi ID22930A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9704321A FR2761992B1 (fr) 1997-04-09 1997-04-09 Nouveaux steroides 4-halogenes, leur procede et intermediaires de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant

Publications (1)

Publication Number Publication Date
ID22930A true ID22930A (id) 1999-12-16

Family

ID=9505672

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW991174A ID22930A (id) 1997-04-09 1998-04-08 Steroid-steroid 4-terhalogenasi baru, proses pembuatan dan zat-zat antaranya, penggunaannya sebagai obat dan komposisi farmasi yang mengandung steroid 4-terhalogenasi

Country Status (31)

Country Link
US (5) US6239121B1 (sk)
EP (1) EP0973793B1 (sk)
JP (1) JP4347420B2 (sk)
KR (1) KR20010006149A (sk)
CN (1) CN1259956A (sk)
AP (1) AP1137A (sk)
AR (1) AR012377A1 (sk)
AT (1) ATE220408T1 (sk)
AU (1) AU750030B2 (sk)
BR (1) BR9809578A (sk)
CA (1) CA2285679A1 (sk)
DE (1) DE69806473T2 (sk)
DK (1) DK0973793T3 (sk)
EA (1) EA002116B1 (sk)
ES (1) ES2178208T3 (sk)
FR (1) FR2761992B1 (sk)
HR (1) HRP980196B1 (sk)
HU (1) HUP0002457A3 (sk)
ID (1) ID22930A (sk)
IL (1) IL132202A (sk)
NO (1) NO315049B1 (sk)
NZ (1) NZ337947A (sk)
PL (1) PL190629B1 (sk)
PT (1) PT973793E (sk)
SK (1) SK284480B6 (sk)
TR (1) TR199902507T2 (sk)
TW (1) TW505621B (sk)
UA (1) UA57073C2 (sk)
WO (1) WO1998045316A1 (sk)
YU (1) YU51199A (sk)
ZA (1) ZA983046B (sk)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2757519B1 (fr) * 1996-12-23 1999-06-11 Hoechst Marion Roussel Inc Steroides substitues en position 11, leur procede de preparation, leur application comme medicament et les compositions pharmaceutiques les renfermant
FR2780060B1 (fr) * 1998-06-23 2000-08-04 Hoechst Marion Roussel Inc Nouveaux 19-nor steroides 17-halogenes, procede et intermediaires de preparation, application comme medicaments et compositions pharmaceutiques les renfermant
FR2826004B1 (fr) * 2001-06-13 2008-03-28 Aventis Pharma Sa Procede de preparation de derives estrogenes
FR2854402B1 (fr) * 2003-04-29 2008-07-04 Aventis Pharma Sa Nouveau procede et intermediaires de preparation de composes 19-nor-steroides
PL2125827T3 (pl) * 2006-12-29 2011-04-29 Hoffmann La Roche Pochodne azaspiro
US20120046461A1 (en) * 2009-01-23 2012-02-23 Northeastern University Steroidal anti-hormone hybrids
FR2942409B1 (fr) * 2009-02-20 2013-07-26 Natacha Voillot Composition pharmaceutique pour la prevention des avortements a repetition.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2640977A2 (en) * 1982-06-11 1990-06-29 Roussel Uclaf New position-11 substituted 19-norsteroids and their application as medicinal products.
US4676932A (en) * 1984-04-09 1987-06-30 The University Of New Mexico Synthesis of 1-haloestradiols
US4859585A (en) * 1986-04-17 1989-08-22 Trustees Of Tufts College In-vitro methods for identifying compositions which are agonists and antagonists of estrogens

Also Published As

Publication number Publication date
US6462211B1 (en) 2002-10-08
TR199902507T2 (xx) 2000-07-21
YU51199A (sh) 2002-09-19
AU750030B2 (en) 2002-07-11
NZ337947A (en) 2001-04-27
FR2761992A1 (fr) 1998-10-16
ATE220408T1 (de) 2002-07-15
KR20010006149A (ko) 2001-01-26
HRP980196B1 (en) 2003-08-31
IL132202A0 (en) 2001-03-19
EA002116B1 (ru) 2001-12-24
AU7339698A (en) 1998-10-30
EP0973793A1 (fr) 2000-01-26
US6472382B2 (en) 2002-10-29
HUP0002457A1 (hu) 2001-02-28
PT973793E (pt) 2002-11-29
NO994908D0 (no) 1999-10-08
UA57073C2 (uk) 2003-06-16
IL132202A (en) 2004-02-19
EA199900909A1 (ru) 2000-04-24
SK136299A3 (en) 2000-05-16
CA2285679A1 (fr) 1998-10-15
SK284480B6 (sk) 2005-04-01
DE69806473T2 (de) 2003-02-13
DE69806473D1 (de) 2002-08-14
US6239121B1 (en) 2001-05-29
PL336116A1 (en) 2000-06-05
HRP980196A2 (en) 1998-12-31
JP4347420B2 (ja) 2009-10-21
NO994908L (no) 1999-12-07
BR9809578A (pt) 2000-07-04
EP0973793B1 (fr) 2002-07-10
US20010039268A1 (en) 2001-11-08
AR012377A1 (es) 2000-10-18
AP9901656A0 (en) 1999-09-30
US20020040135A1 (en) 2002-04-04
TW505621B (en) 2002-10-11
JP2001518891A (ja) 2001-10-16
PL190629B1 (pl) 2005-12-30
US20010005756A1 (en) 2001-06-28
ES2178208T3 (es) 2002-12-16
FR2761992B1 (fr) 1999-06-11
DK0973793T3 (da) 2002-10-28
ZA983046B (en) 1999-04-09
AP1137A (en) 2003-01-12
NO315049B1 (no) 2003-06-30
WO1998045316A1 (fr) 1998-10-15
US20010008941A1 (en) 2001-07-19
CN1259956A (zh) 2000-07-12
US6399766B2 (en) 2002-06-04
HUP0002457A3 (en) 2002-07-29

Similar Documents

Publication Publication Date Title
ID22528A (id) Komposisi farmasi fenofibrat yang memiliki biovabilitas tinggi dan metoda pembuatannya
ID26876A (id) Derivat-derivat benzotiepin 1,1-dioksida, proses pembuatannya, bahan-bahan farmasi yang terdiri dari senyawa-senyawa ini dan penggunaannya
ID26589A (id) 4-haloalkil -3-heterosiklilpiridina dan 4- haloalkil-5-heterosiklilpirimidina proses untuk pembuatannya komposisi yang terdiri darinya dan pemakaiannya sebagai pestisida
DE69812433D1 (de) Anti-estrogene steroide, pharmazeutische zusammensetzungen und verwendungen davon
ID18613A (id) Oksadiazol baru, proses pembuatannya serta penggunaannya sebagai komposisi farmasi
ID30039A (id) Manik-manik baru farmasi pelepasan terkontrol metode pembuatannya dan formulasi berbagai unit yang mengandungnya
HUP0001153A3 (en) Chemically modified polypeptides, process for producing thereof, pharmaceutical compositions comprising these polypeptides and their use
ID22821A (id) Turunan sulfonamida, proses pembuatannya dan penggunaannya sebagai obat
EE04144B1 (et) Farmatseutiline kompositsioon ja selle kasutamine
EE04440B1 (et) Kaparetseptori opioidpeptiidid ja farmatseutilinekompositsioon
EE03594B1 (et) Depooravimiks sobiv farmatseutiline kompositsioon, selle valmistamismeetod ja kasutamine
ID16128A (id) Turunan arilglisinamida baru, proses pembuatannya dan komposisi-komposisi farmasi yang mengandung senyawa ini
ID23436A (id) Senyawa-senyawa akrilonitril, proses untuk produksinya dan pestisida-pestisida yang mengandungnya
ID20137A (id) Turunan propanolamina, proses pembuatannya, sediaan farmasi yang mengandung senyawa ini, dan penggunannya
ID16507A (id) Eprosartan dihidrat dan suatu proses untuk produksi dan formulasinya
AU1897199A (en) Use of formoterol in medicament for inflammation/allergy in upper airways
ID20855A (id) Senyawa turunan imidazolidin baru, pembuatannya, penggunaannya dan sediaan farmasi yang mengandung senyawa tersebut
HUP0000397A3 (en) The use of glucocorticoid substances pasessing a minimal systemic effect for producing pharmaceutical composition for the treatment of joint inflammation
IL125820A0 (en) Therapeutic agent for diabetes and a pharmaceutical composition containing the same
ID22911A (id) Turunan-turunan triazol baru, proses pembuatan dan komposisi-komposisi farmasi yang mengandungnya
ID22930A (id) Steroid-steroid 4-terhalogenasi baru, proses pembuatan dan zat-zat antaranya, penggunaannya sebagai obat dan komposisi farmasi yang mengandung steroid 4-terhalogenasi
FI965193A0 (fi) Triterpeenijohdannainen ja lääkeseos
ATE238057T1 (de) Hormonzusammensetzung welche ein östrogenes mittel und ein progestatives mittel enthält
ID24173A (id) 1,2,3,4,5,6 heksahidro-2-6-metano-3-benzazosin-10-ol, proses pembuatan dan penggunannya untuk obat-obatan
ID26985A (id) Amina-amina polisiklik tiazolidin-2-ilidena, proses pembuatannya, dan penggunaannya a sebagai bahas farmasi